InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: Justfactsmam post# 4145

Sunday, 01/05/2014 3:40:15 PM

Sunday, January 05, 2014 3:40:15 PM

Post# of 55001
Actually I left out main point in IGEN vs. ROCHE...private equity funded the Patent suit all the way...there was no shortage of capital for IGEN, who at the time only had just over $1m in cash. Shareholders made out handsomely as did private equity partners.

Key there...Roche had already incorporated Igen technology into its product used by 7,000 diagnostic customers world-wide.

Not to dis-similar to a situation where Big Tobacco if they violated and used XXII technology in its cigarettes worldwide...IMHO settlement would require big tobacco to buy XXII.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News